Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 15, 2021 - The FDA approved Octapharma’s Octagam 10% (immune globulin intravenous [human]), for the treatment of dermatomyositis in adults.
Download PDF
Return to publications